Fri.Dec 29, 2023

article thumbnail

Regeneron fends off Viatris' Eylea biosimilar with patent win

Fierce Pharma

Armed with a new victory over Viatris in a patent dispute, Regeneron can knock off one contender in the Eylea biosimilar race. | A West Virginia judge found that Viatris' proposed biosimilar stepped on one of the three patents that Regeneron sued over. Shortly after, the company expanded its suit against another biosimilar contender, setting the stage for Regeneron's defense in Eylea's last few months of exclusivity.

220
220
article thumbnail

West Monroe’s 3 Healthcare Outlooks for 2024: AI, Cost Pressures, Dealmaking

MedCity News

There are three key trends for the healthcare industry to follow in 2024, including the rise of AI, increasing cost pressures and M&A activity, according to West Monroe.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA warns of rare hypersensitivity reaction due to antiseizure drugs

Pharmaceutical Technology

FDA warns that levetiracetam and clobazam can cause DRESS, a rare hypersensitivity reaction which can be life threatening.

FDA 111
article thumbnail

Galapagos Counts On Cocoon to Help It Catch Up in Cancer Cell Therapy

MedCity News

Galapagos is a latecomer to CAR T-therapy, but the drugmaker hopes its technology for producing cell therapies at a clinical site will help it stand out. Galapagos has encouraging preliminary data from two early-stage programs and it just begun Phase 1/2 testing of its third cancer cell therapy.

Biopharma 109
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Enveric’s EB-003 selected as lead candidate for mental health disorders

Pharmaceutical Technology

Enveric Biosciences has selected EB-003 as its lead drug candidate from its EVM301 series for difficult-to-treat mental health disorders.

Leads 97
article thumbnail

To Combat Illness in LGBTQ+ Communities, Health Groups Must Tap Into ‘Chosen Circles’

MedCity News

It’s time to transform how government health agencies, pharmaceutical companies, hospitals and other health organizations create and deliver information to the approximately 20 million members of LGBTQ+ communities. Start with paying attention to their “chosen circles” or their trusted sources of information.

More Trending

article thumbnail

The Top 5 Q&As of 2023

PharmExec

Pharm Exec spent the year speaking with some of the most interesting professionals from the life sciences industry.

93
article thumbnail

Optimizing Talent Acquisition: The Evolution of Healthcare Staffing Solutions

Rep-Lite

The evolution of talent acquisition is one of the driving forces shaping staffing solutions in the healthcare sector. As the industry embraces innovation, optimizing talent acquisition becomes necessary. This guide discovers the dynamic changes and advancements that define the evolution of talent acquisition within healthcare staffing. We’ll also explore the role of healthcare staffing solutions in using refined approaches to sourcing and securing top-tier professionals for the critical roles th

article thumbnail

Replay Signs Exclusive Licensing Agreements with NIH and Miltenyi Biotec for Cell Therapy Development and Manufacturing

PharmaTech

Through Syena, its oncology-focused product company, Replay will develop and manufacture T-cell receptor and natural killer cell therapies with the NIH and Miltenyi Biotec.

article thumbnail

Top 3 Manufacturing and Packaging Articles of 2023

Pharmaceutical Commerce

Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

The Decline and Fall of the Clinician–Scientist

PharmaTech

Clinician-Scientists are vital innovation spark plugs, accounting for 40% of Nobel awards in Physiology or Medicine, and two thirds of Big Pharma CSOs.

article thumbnail

Top 5 Pharmacy Times Pediatrics Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read pediatrics-related articles on Pharmacy Times in 2023.

49
article thumbnail

Top 5 Pharmacy Times Oncology Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read oncology-related articles on Pharmacy Times in 2023.

49
article thumbnail

Top 5 Pharmacy Times Health Systems Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read health systems-related articles on Pharmacy Times in 2023.

26
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud